Single-Cell Analysis of the Human T Regulatory Population Uncovers Functional Heterogeneity and Instability within FOXP3+ Cells
暂无分享,去创建一个
E. Sgouroudis | C. Piccirillo | Ciriaco A. Piccirillo | Eva d’Hennezel | Ekaterina Yurchenko | Evridiki Sgouroudis | Valérie Hay | V. Hay | E. Yurchenko | E. d’Hennezel | Evridiki Sgouroudis | Eva d’Hennezel
[1] T. Nomura,et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. , 2009, Immunity.
[2] T. Gingeras,et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.
[3] Ethan M. Shevach,et al. Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function , 2004, The Journal of Immunology.
[4] R. Andreesen,et al. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation , 2009, European journal of immunology.
[5] S. Ziegler,et al. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] N. Amariglio,et al. TNF Activates a NF-κB–Regulated Cellular Program in Human CD45RA– Regulatory T Cells that Modulates Their Suppressive Function , 2010, The Journal of Immunology.
[7] D. Mason,et al. Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro , 2001, European journal of immunology.
[8] P. Janson,et al. FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans , 2008, PloS one.
[9] Ruslan Medzhitov,et al. Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.
[10] G. Szot,et al. Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes , 2009, Diabetes.
[11] D. Hafler,et al. FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.
[12] C. Benoist,et al. Genomic definition of multiple ex vivo regulatory T cell subphenotypes , 2010, Proceedings of the National Academy of Sciences.
[13] W. Selby,et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.
[14] T. Nomura,et al. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. , 2009, Immunity.
[15] M. Levings,et al. Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. , 2007, Blood.
[16] P. Krammer,et al. Rapid Suppression of Cytokine Transcription in Human CD4+CD25− T Cells by CD4+Foxp3+ Regulatory T Cells: Independence of IL-2 Consumption, TGF-β, and Various Inhibitors of TCR Signaling1 , 2007, The Journal of Immunology.
[17] Katharina Fleischhauer,et al. Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.
[18] A. Rudensky,et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells , 2007, Nature.
[19] S. Barry,et al. Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease , 2009, Journal of Clinical Immunology.
[20] K. Wood,et al. Regulatory lymphocytes: Regulatory T cells in transplantation tolerance , 2003, Nature Reviews Immunology.
[21] Li Li,et al. Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.
[22] Ethan M. Shevach,et al. CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.
[23] S. Ziegler,et al. Insights into transcriptional regulation by FOXP3. , 2006, Frontiers in bioscience : a journal and virtual library.
[24] Xiaomin Song,et al. TGF-β and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3 , 2008, Proceedings of the National Academy of Sciences.
[25] J. Casanova,et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.
[26] T. Nomura,et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1 , 2007, Nature.
[27] T. Nomura,et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. , 2004, International immunology.
[28] F. Denizot,et al. A new member of the immunoglobulin superfamily—CTLA-4 , 1987, Nature.
[29] J. Stroud,et al. FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT , 2006, Cell.
[30] B. Malissen,et al. Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity , 2009, Proceedings of the National Academy of Sciences.
[31] Yasmine Belkaid,et al. Natural regulatory T cells in infectious disease , 2005, Nature Immunology.
[32] J. Bluestone,et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo , 2009, Nature Immunology.
[33] M. Roncarolo,et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. , 2007, International immunology.
[34] C. Baecher-Allan,et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. , 2009, Blood.
[35] E. d'Hennezel,et al. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. , 2009, The New England journal of medicine.
[36] S. Zelenay,et al. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions , 2009, European journal of immunology.
[37] E. Bettelli,et al. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[38] E. d'Hennezel,et al. Analysis of human FOXP3+ Treg cells phenotype and function. , 2011, Methods in molecular biology.
[39] D. Wraith,et al. Natural and Induced Regulatory T Cells , 2004, Annals of the New York Academy of Sciences.
[40] C. Benoist,et al. The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells , 2008, The Journal of experimental medicine.
[41] M. Karim,et al. Regulatory T cells in transplantation. , 2002, Current opinion in immunology.
[42] Xiaomin Song,et al. FOXP3 ensembles in T‐cell regulation , 2006, Immunological reviews.
[43] C. Baecher-Allan,et al. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells. , 2005, Clinical immunology.
[44] K. Kretschmer,et al. DNA methylation controls Foxp3 gene expression , 2008, European journal of immunology.
[45] R. DePinho,et al. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells , 2010, Nature Immunology.
[46] R. Andreesen,et al. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. , 2006, Blood.
[47] H. Waldmann,et al. Regulatory T cells in transplantation tolerance. , 2005, Current topics in microbiology and immunology.
[48] Wayne W. Hancock,et al. Transcriptional Regulation by Foxp3 Is Associated with Direct Promoter Occupancy and Modulation of Histone Acetylation* , 2006, Journal of Biological Chemistry.
[49] J. Buer,et al. Developmental Stage, Phenotype, and Migration Distinguish Naive- and Effector/Memory-like CD4+ Regulatory T Cells , 2004, The Journal of experimental medicine.
[50] M. Levings,et al. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. , 2006, Advances in immunology.
[51] H. Weiner,et al. Induction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cells , 2001, Immunological reviews.
[52] G. Freeman,et al. CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.
[53] J. Rowe,et al. Allogeneic induced human FOXP3+IFN‐γ+ T cells exhibit selective suppressive capacity , 2009, European journal of immunology.
[54] Christophe Benoist,et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. , 2007, Immunity.
[55] George Coukos,et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.
[56] K. Wood. Regulatory T Cells in Transplantation , 2011, Transplantation proceedings.
[57] R. Winchester,et al. Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells , 1979, The Journal of experimental medicine.
[58] S. Ziegler,et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. , 2005, The Journal of clinical investigation.
[59] Y. Lau,et al. Generation of human Th1‐like regulatory CD4+ T cells by an intrinsic IFN‐γ‐ and T‐bet‐dependent pathway , 2011, European journal of immunology.
[60] M. Battaglia,et al. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells. , 2008, International immunology.
[61] V. Kuchroo,et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation , 2007, Nature Medicine.
[62] E. Holler,et al. Isolation of CD4+CD25+ regulatory T cells for clinical trials. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[63] P. Pandolfi,et al. GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease , 2004, The Journal of experimental medicine.